These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21739117)

  • 1. No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample.
    Renner TJ; Nguyen TT; Romanos M; Walitza S; Röser C; Reif A; Schäfer H; Warnke A; Gerlach M; Lesch KP
    Atten Defic Hyperact Disord; 2011 Sep; 3(3):285-9. PubMed ID: 21739117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder.
    Kim CH; Waldman ID; Blakely RD; Kim KS
    Ann N Y Acad Sci; 2008; 1129():256-60. PubMed ID: 18591486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).
    Ramoz N; Boni C; Downing AM; Close SL; Peters SL; Prokop AM; Allen AJ; Hamon M; Purper-Ouakil D; Gorwood P
    Neuropsychopharmacology; 2009 Aug; 34(9):2135-42. PubMed ID: 19387424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
    Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association.
    Rippel CA; Kobets AJ; Yoon DY; Williams PN; Shugart YY; Bridges DD; Vandenbergh DJ; Singer HS
    Psychiatr Genet; 2006 Oct; 16(5):179-80. PubMed ID: 16969268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association studies of -3081(A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population.
    Joung Y; Kim CH; Moon J; Jang WS; Yang J; Shin D; Lee S; Kim KS
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):691-694. PubMed ID: 19685476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder.
    Doyle C; Brookes K; Simpson J; Park J; Scott S; Coghill DR; Hawi Z; Kirley A; Gill M; Kent L
    Neurosci Lett; 2009 Sep; 462(2):179-81. PubMed ID: 19576958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
    Kustanovich V; Ishii J; Crawford L; Yang M; McGough JJ; McCracken JT; Smalley SL; Nelson SF
    Mol Psychiatry; 2004 Jul; 9(7):711-7. PubMed ID: 14699430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder.
    Park S; Kim JW; Yang YH; Hong SB; Park MH; Kim BN; Shin MS; Yoo HJ; Cho SC
    Behav Brain Funct; 2012 May; 8():22. PubMed ID: 22591463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD.
    Lee SH; Kim SW; Lee MG; Yook KH; Greenhill LL; Fradin KN; Hong HJ
    Psychiatry Res; 2011 Apr; 186(2-3):338-44. PubMed ID: 20863575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan.
    Shang CY; Gau SS; Liu CM; Hwu HG
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):421-8. PubMed ID: 20800641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD.
    Smoller JW; Biederman J; Arbeitman L; Doyle AE; Fagerness J; Perlis RH; Sklar P; Faraone SV
    Biol Psychiatry; 2006 Mar; 59(5):460-7. PubMed ID: 16197923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A haplotype of the norepinephrine transporter gene (SLC6A2) is associated with visual memory in attention-deficit/hyperactivity disorder.
    Shang CY; Chiang HL; Gau SS
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():89-96. PubMed ID: 25554436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder.
    Kim CH; Hahn MK; Joung Y; Anderson SL; Steele AH; Mazei-Robinson MS; Gizer I; Teicher MH; Cohen BM; Robertson D; Waldman ID; Blakely RD; Kim KS
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19164-9. PubMed ID: 17146058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-control association study of the polymorphism at the promoter region of the DRD4 gene in Korean boys with attention deficit-hyperactivity disorder: evidence of association with the -521 C/T SNP.
    Yang JW; Jang WS; Hong SD; Ji YI; Kim DH; Park J; Kim SW; Joung YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):243-8. PubMed ID: 17850946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of norepinephrine transporter (NET, SLC6A2) genotype with ADHD-related phenotypes: findings of a longitudinal study from birth to adolescence.
    Hohmann S; Hohm E; Treutlein J; Blomeyer D; Jennen-Steinmetz C; Schmidt MH; Esser G; Banaschewski T; Brandeis D; Laucht M
    Psychiatry Res; 2015 Apr; 226(2-3):425-33. PubMed ID: 25724484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.
    Retz W; Rösler M; Kissling C; Wiemann S; Hünnerkopf R; Coogan A; Thome J; Freitag C
    J Neural Transm (Vienna); 2008; 115(2):323-9. PubMed ID: 17994190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of significant association between -1021C-->T polymorphism in the dopamine beta hydroxylase gene and attention deficit hyperactivity disorder.
    Bhaduri N; Mukhopadhyay K
    Neurosci Lett; 2006 Jul; 402(1-2):12-6. PubMed ID: 16616989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: a family-based and case-control association study in a Korean sample.
    Cho SC; Kim JW; Kim BN; Hwang JW; Park M; Kim SA; Cho DY; Yoo HJ; Chung US; Son JW; Park TW
    Neuropsychobiology; 2008; 57(3):131-8. PubMed ID: 18552510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB.
    Ribasés M; Ramos-Quiroga JA; Hervás A; Bosch R; Bielsa A; Gastaminza X; Artigas J; Rodriguez-Ben S; Estivill X; Casas M; Cormand B; Bayés M
    Mol Psychiatry; 2009 Jan; 14(1):71-85. PubMed ID: 17938636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.